Subject(s)

Biosimilar Pharmaceuticals/therapeutic use , Biosimilar Pharmaceuticals/adverse effects , Biosimilar Pharmaceuticals/economics , Caribbean Region , Cost-Benefit Analysis/legislation & jurisprudence , Drug Approval/economics , Drug Approval/legislation & jurisprudence , Drug Substitution/economics , Drugs, Generic/adverse effects , Drugs, Generic/economics , Drugs, Generic/therapeutic use , Patents as Topic/legislation & jurisprudence , Treatment Outcome , United States , United States Food and Drug Administration/legislation & jurisprudence